Intersect ENT, Inc
XENT
XENT was delisted on the 12th of May, 2022.
108 hedge funds and large institutions have $373M invested in Intersect ENT, Inc in 2020 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 45 increasing their positions, 33 reducing their positions, and 28 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
36% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 33
13% more capital invested
Capital invested by funds: $331M → $373M (+$42.3M)
11% less funds holding
Funds holding: 121 → 108 (-13)
29% less call options, than puts
Call options by funds: $2.05M | Put options by funds: $2.89M
46% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 28
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$4.84M |
| 2 |
PVI
Pura Vida Investments
New York
|
+$3.98M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$3.25M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
+$3.07M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$3.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Polar Capital
London,
United Kingdom
|
-$11M |
| 2 |
Westfield Capital Management
Boston,
Massachusetts
|
-$5.41M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.56M |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$3.1M |
| 5 |
Jennison Associates
New York
|
-$2.99M |
XENT Hedge Fund Activity: Q2 2020 in Review
108 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q2 2020, worth a combined $373M — up 13% from $331M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of XENT and 15 opened new positions — a net loss of 13 holders — while 33 trimmed existing stakes and 45 added.
The largest buyer was D.E. Shaw & Co, adding an estimated $4.84M. The largest seller was Polar Capital, cutting an estimated $11M.
- 108 institutional investors held Intersect ENT, Inc (XENT) as of Q2 2020, down from 121 in Q1 2020.
- Funds reported $373M of Intersect ENT, Inc stock for Q2 2020, up 13% quarter-over-quarter.
- 15 funds opened new Intersect ENT, Inc positions in Q2 2020 and 28 closed out, a net change of -13 holders.
- The largest Intersect ENT, Inc buyer in Q2 2020 was D.E. Shaw & Co, an estimated $4.84M added.
- The largest Intersect ENT, Inc seller in Q2 2020 was Polar Capital, an estimated $11M sold.
Based on aggregated 13F filings for Q2 2020.